Publication:
Estimation of COVID-19 vaccine effectiveness against hospitalisation in individuals aged ≥ 65 years using electronic health registries; a pilot study in four EU/EEA countries, October 2021 to March 2022

Simple item page
dc.contributor.authorSentís, Alexis
dc.contributor.authorKislaya, Irina
dc.contributor.authorNicolay, Nathalie
dc.contributor.authorMeijerink, Hinta
dc.contributor.authorStarrfelt, Jostein
dc.contributor.authorMartínez-Baz, Iván
dc.contributor.authorCastilla Catalán, Jesús
dc.contributor.authorNielsen, Katrine Finderup
dc.contributor.authorHansen, Christian Holm
dc.contributor.authorEmborg, Hanne-Dorthe
dc.contributor.authorNardone, Anthony
dc.contributor.authorDerrough, Tarik
dc.contributor.authorValenciano, Marta
dc.contributor.authorNunes, Baltazar
dc.contributor.authorMonge, Susana
dc.contributor.authorVEBIS-Lot4 working group
dc.contributor.authorLarrauri, Amparo
dc.contributor.authorMazagatos, Clara
dc.contributor.funderUnión Europea. European Centre for Disease Prevention and Control (ECDC)
dc.date.accessioned2023-02-07T11:30:26Z
dc.date.available2023-02-07T11:30:26Z
dc.date.issued2022-07
dc.description.abstractBy employing a common protocol and data from electronic health registries in Denmark, Navarre (Spain), Norway and Portugal, we estimated vaccine effectiveness (VE) against hospitalisation due to COVID-19 in individuals aged ≥ 65 years old, without previous documented infection, between October 2021 and March 2022. VE was higher in 65-79-year-olds compared with ≥ 80-year-olds and in those who received a booster compared with those who were primary vaccinated. VE remained high (ca 80%) between ≥ 12 and < 24 weeks after the first booster administration, and after Omicron became dominant.es_ES
dc.description.peerreviewedSíes_ES
dc.description.sponsorshipAll the organisations involved have received funding from the European Centre for Disease Prevention and Control (ECDC) implementing Framework Contract ECDC/2021/018 ‘Vaccine effectiveness and impact of COVID-19 vaccines through routinely collected exposure and outcome using health registries’ (RS/2022/DTS/24104).es_ES
dc.format.number30es_ES
dc.format.page2200551es_ES
dc.format.volume27es_ES
dc.identifier.citationEuro Surveill. 2022 Jul;27(30):2200551.es_ES
dc.identifier.doi10.2807/1560-7917.ES.2022.27.30.2200551es_ES
dc.identifier.e-issn1560-7917es_ES
dc.identifier.journalEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletines_ES
dc.identifier.pubmedID35904059es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/15461
dc.language.isoenges_ES
dc.publisherCenters for Disease Control and Prevention (CDC)
dc.repisalud.centroISCIII::Centro Nacional de Epidemiologíaes_ES
dc.repisalud.institucionISCIIIes_ES
dc.rights.accessRightsopen accesses_ES
dc.rights.licenseAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectCOVID-19es_ES
dc.subjectDelta variantes_ES
dc.subjectOmicron variantes_ES
dc.subjectVaccination booster dosees_ES
dc.subjectVaccination primary coursees_ES
dc.subjectVaccine effectivenesses_ES
dc.subject.meshCOVID-19es_ES
dc.subject.meshCOVID-19 Vaccineses_ES
dc.subject.meshAgedes_ES
dc.subject.meshElectronicses_ES
dc.subject.meshHospitalizationes_ES
dc.subject.meshHumanses_ES
dc.subject.meshPilot Projectses_ES
dc.subject.meshRegistrieses_ES
dc.subject.meshVaccine Efficacyes_ES
dc.titleEstimation of COVID-19 vaccine effectiveness against hospitalisation in individuals aged ≥ 65 years using electronic health registries; a pilot study in four EU/EEA countries, October 2021 to March 2022es_ES
dc.typejournal articlees_ES
dc.type.hasVersionVoRes_ES
dspace.entity.typePublication
relation.isAuthorOfPublicatione77e1f2d-b4e2-4ba5-a853-c2795850dcae
relation.isAuthorOfPublicatione177bf8c-3734-480b-a2ae-4ae67491776c
relation.isAuthorOfPublication.latestForDiscoverye77e1f2d-b4e2-4ba5-a853-c2795850dcae
relation.isFunderOfPublication78e868cc-0192-448d-bcb1-98d618a7cee4
relation.isFunderOfPublication.latestForDiscovery78e868cc-0192-448d-bcb1-98d618a7cee4
relation.isPublisherOfPublicationa8762703-85e3-4e0e-bcd1-f6ee71312bf8
relation.isPublisherOfPublication.latestForDiscoverya8762703-85e3-4e0e-bcd1-f6ee71312bf8

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
EstimationCOVID-19VaccineEffectiveness_2022.pdf
Size:
223.05 KB
Format:
Adobe Portable Document Format
Description:
Download

Collections

Centro Nacional de Epidemiología (CNE)
IdiSNA - Instituto de Investigación Sanitaria de Navarra (Navarra)